158 集

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman Timmerman Report

    • 科學

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Ep160: Abe Ceesay on Precision Neuroscience

    Ep160: Abe Ceesay on Precision Neuroscience

    Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.

    • 1 小時 8 分鐘
    Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.

    • 1 小時 7 分鐘
    Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.

    • 1 小時
    Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

    Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

    Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.

    • 56 分鐘
    Ep156: David Liu on New Tools and Techniques for Biology

    Ep156: David Liu on New Tools and Techniques for Biology

    David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.

    • 1 小時 52 分鐘
    Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.

    • 1 小時 2 分鐘

關於科學的熱門 Podcast

探索大腦的會談地圖
林煜軒醫師
老高與小茉 Mr & Mrs Gao
老高與小茉 Mr & Mrs Gao
泛泛泛科學
PanSci
The Science of Happiness
PRX and Greater Good Science Center
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Thinking Allowed
BBC Radio 4

你可能也會喜歡

The Readout Loud
STAT
Business Of Biotech
Matt Pillar
Raising Health
Andreessen Horowitz
BioCentury This Week
BioCentury
Biotech 2050 Podcast
Biotech 2050
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

HeadStepper Media的更多節目

The Workup
Connecticut Health Investigative Team
Strings and Things
Peppergreen Media
About Men Radio
Pedro Rafael Rosado & Christopher Mele
POP | TECH | JAM
J.D. Biersdorfer and Pedro Rafael Rosado